Molly Harper, Director at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 14,000 shares at $14.37 ($201K) on 2023-12-15, disclosed to the SEC on 2023-12-19.
Open-market sale of $201k CPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.37 | 10,000 | $144K | 71.3% |
| 2 | $14.43 | 4,000 | $58K | 28.7% |
| Total | $14.39 avg | 14,000 | $201K | 100% |
| Filing → |
| CPRX | SELL | 2024-06-05 | $174K | — | Filing → |